The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH
Clinical trial NCT07134907 · COMPLETED
Trial details
- NCT number
- NCT07134907
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-18
- Primary completion
- 2024-07-09
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.